Mavromanolakis E, Maraki S, Samonis G, Tselentis Y, Cranidis A
Department of Urology, University Hospital of Heraklion, Crete, Greece.
J Chemother. 1997 Jun;9(3):203-7. doi: 10.1179/joc.1997.9.3.203.
The effects of antibiotics used for prophylaxis in women with recurrent urinary tract infections (UTIs) on the aerobic intestinal flora were investigated. Twenty-one patients with recurrent UTIs were randomly divided into three groups. The patients of each group received monotherapy with oral norfloxacin, trimethoprim-sulfamethoxazole or nitrofurantoin for one month. Urine and stool quantitative aerobic cultures were performed before prophylaxis, 2 and 4 weeks after the initiation of therapy, and 2 weeks after antibiotics were discontinued. The gram-negative aerobic flora was strongly suppressed during the administration of norfloxacin and trimethoprim-sulfamethoxazole, while Enterococcus spp. were not affected. Resistant strains of Escherichia coli were detected in two patients, one in the norfloxacin and one in the trimethoprim-sulfamethoxazole group. The aerobic intestinal flora was not affected by nitrofurantoin. These findings help in the selection of the most appropriate antimicrobial agent for prophylaxis in recurrent UTIs, so as to reduce the possibility of emergence of resistant bacterial strains.
研究了用于复发性尿路感染(UTIs)女性预防性治疗的抗生素对需氧肠道菌群的影响。21例复发性UTIs患者被随机分为三组。每组患者接受口服诺氟沙星、甲氧苄啶 - 磺胺甲恶唑或呋喃妥因单药治疗1个月。在预防治疗前、治疗开始后2周和4周以及停用抗生素后2周进行尿液和粪便需氧菌定量培养。在使用诺氟沙星和甲氧苄啶 - 磺胺甲恶唑期间,革兰氏阴性需氧菌群受到强烈抑制,而肠球菌属未受影响。在两名患者中检测到大肠埃希菌耐药菌株,一名在诺氟沙星组,一名在甲氧苄啶 - 磺胺甲恶唑组。呋喃妥因未影响需氧肠道菌群。这些发现有助于选择最适合复发性UTIs预防性治疗的抗菌药物,以降低耐药菌株出现的可能性。